We are live on ! Find out more

2,785 hedge funds and large institutions have $129B invested in Amgen in 2024 Q2 according to their latest regulatory filings, with 209 funds opening new positions, 1,143 increasing their positions, 1,065 reducing their positions, and 100 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more first-time investments, than exits

New positions opened: 209 | Existing positions closed: 100

58% more funds holding in top 10

Funds holding in top 10: 5587 (+32)

19% more call options, than puts

Call options by funds: $2.6B | Put options by funds: $2.18B

10% more capital invested

Capital invested by funds: $117B → $129B (+$11.8B)

3% more funds holding

Funds holding: 2,7162,785 (+69)

7% more repeat investments, than reductions

Existing positions increased: 1,143 | Existing positions reduced: 1,065

0.11% less ownership

Funds ownership: 77%76.9% (-0.11%)

Holders
2,785
Holders Change
+69
Holders Change %
+2.54%
% of All Funds
40.22%
Holding in Top 10
87
Holding in Top 10 Change
+32
Holding in Top 10 Change %
+58.18%
% of All Funds
1.26%
New
209
Increased
1,143
Reduced
1,065
Closed
100
Calls
$2.6B
Puts
$2.18B
Net Calls
+$421M
Net Calls Change
+$284M
Name Holding Trade Value Shares
Change
Change in
Stake
Amundi
26
Amundi
France
$1.03B -$7.8M -26,542 -0.8%
Invesco
27
Invesco
Georgia
$1.02B +$52.1M +177,255 +6%
State Farm Mutual Automobile Insurance
28
State Farm Mutual Automobile Insurance
Illinois
$849M
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$844M +$47.7M +162,223 +6%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$832M -$26.4M -89,818 -3%
JP Morgan Chase
31
JP Morgan Chase
New York
$814M -$303M -1,032,225 -28%
Boston Partners
32
Boston Partners
Massachusetts
$718M +$16.8M +57,076 +3%
Franklin Resources
33
Franklin Resources
California
$650M +$114M +388,965 +23%
Ameriprise
34
Ameriprise
Minnesota
$608M -$9M -30,634 -2%
HSBC Holdings
35
HSBC Holdings
United Kingdom
$590M +$60.5M +205,942 +12%
Barclays
36
Barclays
United Kingdom
$589M -$722M -2,459,106 -57%
Nordea Investment Management
37
Nordea Investment Management
Sweden
$568M +$1.7M +5,784 +0.3%
BGC
38
Beutel, Goodman & Co
Ontario, Canada
$523M +$24.1M +82,036 +5%
Swiss National Bank
39
Swiss National Bank
Switzerland
$496M -$4.7M -16,000 -1%
AllianceBernstein
40
AllianceBernstein
Tennessee
$487M -$116M -395,420 -20%
Sumitomo Mitsui Trust Group
41
Sumitomo Mitsui Trust Group
Japan
$484M -$32.6M -111,072 -7%
MBI
42
Montrusco Bolton Investments
Quebec, Canada
$475M -$74.6M -254,045 -14%
Stifel Financial
43
Stifel Financial
Missouri
$457M +$8.37M +28,475 +2%
Envestnet Asset Management
44
Envestnet Asset Management
Illinois
$440M +$31.5M +107,134 +8%
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$415M +$21.5M +73,041 +6%
Federated Hermes
46
Federated Hermes
Pennsylvania
$412M -$45.4M -154,489 -10%
CWP
47
Capital Wealth Planning
Florida
$383M +$115M +392,727 +47%
Allianz Asset Management
48
Allianz Asset Management
Germany
$371M -$47.7M -162,393 -12%
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$369M -$59M -200,788 -15%
SCM
50
Smead Capital Management
Arizona
$354M +$17.5M +59,456 +6%

AMGN Hedge Fund Activity: Q2 2024 in Review

2,785 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q2 2024, worth a combined $129B — up 10% from $117B a quarter earlier.

Buyers outnumbered sellers: 209 funds opened new AMGN positions and 100 closed out — a net gain of 109 holders — while 1,143 added to existing stakes and 1,065 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $653M. The largest seller was Barclays, cutting an estimated $722M.

  • 2,785 institutional investors held Amgen (AMGN) as of Q2 2024, up from 2,716 in Q1 2024.
  • Funds reported $129B of Amgen stock for Q2 2024, up 10% quarter-over-quarter.
  • 209 funds opened new Amgen positions in Q2 2024 and 100 closed out, a net change of +109 holders.
  • The largest Amgen buyer in Q2 2024 was Janus Henderson Group, an estimated $653M added.
  • The largest Amgen seller in Q2 2024 was Barclays, an estimated $722M sold.

Based on aggregated 13F filings for Q2 2024.